<ѻýҕl>FDA Approves First Renal Denervation System for Hypertensionѻýҕl> Catheter-based technology will finally enter the market with ultrasound-based device Nov 08, 2023
<ѻýҕl>Hospitalizations After Fake Ozempic; Abortion Rights Win Big; Ketamine Use Boomsѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Nov 08, 2023
<ѻýҕl>Kidney Week Roundup: Cell Therapy Cuts Immunosuppressive Drug Use Post-Transplantѻýҕl> Plus: bardoxolone methyl for diabetic kidney disease and spironolactone in hemodialysis patients Nov 07, 2023
<ѻýҕl>Novel Aldosterone Synthase Inhibitor Cuts Albuminuria in Phase II Trialѻýҕl> Trial tested BI 690517 with and without empagliflozin Nov 06, 2023
<ѻýҕl>Heart Injuries Suggest Reconsideration of Holding BP Meds for Surgeryѻýҕl> Pause on ACE inhibitors, ARBs yields more acute hypertension with no prevention of hypotension Nov 06, 2023
<ѻýҕl>Kidney Transplant Rates Stubbornly Resist Systems Intervention in Canadaѻýҕl> Multi-pronged approach to boost living and deceased donor transplant fails in randomized trial Nov 06, 2023
<ѻýҕl>Sparsentan Bests Irbesartan for Preserving Kidney Function in IgA Nephropathyѻýҕl> Proteinuria reduction and slower eGFR decline in 2-year PROTECT trial Nov 05, 2023
<ѻýҕl>ERA and SGLT2 Inhibitor Combo Cuts Albuminuria in Chronic Kidney Diseaseѻýҕl> But ZENITH-CKD trial had to pivot to only using low-dose zibotentan due to fluid retention Nov 05, 2023
<ѻýҕl>Heat and Cardiovascular Death; Time-Restricted Eating or Caloric Restriction in T2Dѻýҕl> Also in TTHealthWatch: managing nasal airway obstruction Nov 04, 2023 podcast
<ѻýҕl>Pharmacist Prescribing for BP Control Makes Economic Senseѻýҕl> Clinical benefits of pharmacist-prescribed antihypertensives known for years Nov 03, 2023
<ѻýҕl>Sparsentan Failed to Preserve Kidney Function Over Time in FSGSѻýҕl> However, more patients on the drug achieved partial remission of proteinuria vs irbesartan Nov 03, 2023
<ѻýҕl>Mid-Stage Win for Novel IgA Nephropathy Drugѻýҕl> APRIL-neutralizing antibody sibeprenlimab reduced proteinuria and stabilized eGFR Nov 02, 2023
<ѻýҕl>Fecal Transplants in Kidney Recipients Reduced Resistant Pathogensѻýҕl> Multidrug resistant organisms replaced by competing antibiotic-susceptible relatives Nov 01, 2023
<ѻýҕl>Year in Review: Type 2 Diabetesѻýҕl> New approvals, guidance on GLP-1s before surgery, and access issues led the news in 2023 Nov 01, 2023
<ѻýҕl>Wegovy and Thyroid Cancer; Maine Shooter's Mental Health; 469 Heat Deathsѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Oct 30, 2023
<ѻýҕl>Tricuspid Valve Replacement Safe, Effective in Pivotal Trialѻýҕl> Outcome data still awaited after positive interim results Oct 27, 2023
<ѻýҕl>Another Study Highlights Metformin's Dementia Protection Propertiesѻýҕl> Association appeared irrespective of HbA1c level Oct 25, 2023
<ѻýҕl>Cruise Line Found Negligent About COVID; Dialysis Machine Recall; MRI Injures Nurseѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Oct 25, 2023
<ѻýҕl>Low-Risk TAVR Converging or Diverging With Surgical Outcomes, Depending on the Valveѻýҕl> Intermediate-term reports from PARTNER 3 and Evolut Low Risk trials Oct 24, 2023
<ѻýҕl>CVS Pulls Phenylephrine Cold Meds; Doc's Murder/Suicide; Red Meat and Diabetesѻýҕl> Health news and commentary from around the Web gathered by ѻýҕl staff Oct 20, 2023
<ѻýҕl>Highly Potent Statin Stands Out for Diabetes, Cataract Risksѻýҕl> Head-to-head comparison of rosuvastatin vs atorvastatin in LODESTAR trial Oct 19, 2023
<ѻýҕl>How to Deprescribe Dialysis After Patients Leave the Hospitalѻýҕl> Acute kidney injury patients should not be left on dialysis longer than necessary Oct 19, 2023
<ѻýҕl>FDA Approves First Phosphate Absorption Inhibitor for CKDѻýҕl> Tenapanor indicated for adults on dialysis who fail on phosphate binders Oct 18, 2023
<ѻýҕl>Antibiotic Combo for Acute Infection Cleared of Kidney Riskѻýҕl> Use of cefepime meanwhile resulted in more neurological dysfunction Oct 16, 2023
<ѻýҕl>'Surprising' Contribution of Pulmonary Hypertension to ARDS Outcomesѻýҕl> Coexisting conditions spell markedly poor clinical course Oct 12, 2023
<ѻýҕl>Modest Risks Come With Moving Fast on HF Drugs After Acute Eventѻýҕl> STRONG-HF analysis details the impact Oct 10, 2023
<ѻýҕl>Risk of Contrast Media Causing Acute Kidney Injury Is Overblown, Study Findsѻýҕl> Despite restrictions on its use, an association with kidney injury hasn't been shown Oct 10, 2023
<ѻýҕl>Time to Recognize Cardiovascular-Kidney-Metabolic Syndrome, AHA Saysѻýҕl> Pooled cohort equations will make way for new CKM risk calculator Oct 09, 2023
<ѻýҕl>Inflammation of the Aorta; Afib in the Hospitalѻýҕl> Also in TTHealthWatch: standards for osteoporosis screening and HbA1c in premenopausal women Oct 07, 2023 podcast
<ѻýҕl>CPAP Turns in Mixed Results for Patients With Diabetic Eye Diseaseѻýҕl> Slower progression of retinal disease, but an increase in microhemorrhages Oct 06, 2023
<ѻýҕl>Smoking-Related Metabolic Changes Partly Drive Type 2 Diabetes Riskѻýҕl> Those with the most metabolic changes, genetic risk had a threefold higher diabetes risk Oct 06, 2023
<ѻýҕl>Faster-Acting Insulin Aspart Safe for Pregnant Women With Diabetesѻýҕl> The faster formulation led to fewer hypoglycemia events versus conventional insulin aspart Oct 06, 2023
<ѻýҕl>Adherence Matters for CVD Secondary Prevention in CPAP Usersѻýҕl> Questionable benefit may hinge on number of hours used Oct 05, 2023
<ѻýҕl>Hybrid Closed-Loop Insulin System for T1D Safe, Effective During Pregnancyѻýҕl> However, no FDA-approved systems have a pregnancy indication yet Oct 05, 2023
<ѻýҕl>Mixed Bag for Early Metformin in Gestational Diabetesѻýҕl> EMERGE trial misses on primary endpoint, but secondary outcomes suggest potential benefit Oct 03, 2023
<ѻýҕl>Adding Tirzepatide to Basal Insulin Cuts HbA1c in Poorly Controlled T2Dѻýҕl> Results with the GIP/GLP-1 receptor agonist were statistically superior to added insulin lispro Oct 03, 2023
<ѻýҕl>Repeat Tests for Inflammation Aid Prognosis After Acute Heart Failureѻýҕl> Mortality predicted by cumulative hsCRP levels over time Oct 02, 2023
<ѻýҕl>FDA OKs Another Injectable for Rare Kidney Disorderѻýҕl> Nedosiran approved for patients ages 9 years and older with primary hyperoxaluria type 1 Oct 02, 2023
<ѻýҕl>FDA Adds Intestinal Blockage Reports to Ozempic Labelingѻýҕl> Joins other approved GLP-1 receptor agonists in noting the potential adverse reaction Sep 28, 2023
<ѻýҕl>Postmenopausal Fracture Risk for SGLT2 Inhibitors Similar to Other Diabetes Drugsѻýҕl> Lower risk compared with DPP-4 inhibitors, and similar risk versus GLP-1 receptor agonists Sep 26, 2023